Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Nature Communications|November 10, 2025
Deep immune profiling delineates hallmarks of disease heterogeneity in extrapulmonary tuberculosisSebastian J Theobald, Kilian Dahm, Dinah Lange, et al.
Open Forum Infectious Diseases|December 18, 2024
Diagnostic Accuracy of Lung and Abdominal Ultrasound for Tuberculosis in a German Multicenter Cohort of Patients With Presumed Tuberculosis DiseaseStefan Fabian Weber, Peter Wolf, Nils Wetzstein, et al.
Infection|March 11, 2025
Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort studyAngela Klingmüller, Marie Feldmann, Samuel Rohr, et al.
The Lancet Regional Health. Europe|May 24, 2021
Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort studyMax Augustin, Philipp Schommers, Melanie Stecher, et al.
Cell Host & Microbe|May 13, 2021
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humansKanika Vanshylla, Veronica Di Cristanziano, Franziska Kleipass, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 4, 2020
Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020Max Augustin, Philipp Schommers, Isabelle Suárez, et al.
Eclinicalmedicine|August 30, 2021
Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools - a cluster randomised trialAlexander Joachim, Felix Dewald, Isabelle Suárez, et al.
Infection|June 27, 2022
Implementing the Lolli-Method and pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools: a pilot projectAlina Chloé Kretschmer, Lena Junker, Felix Dewald, et al.
The Lancet. Microbe|May 11, 2022
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trialHenning Gruell, Jesper D Gunst, Yehuda Z Cohen, et al.
Pediatrics|April 10, 2024
SARS-CoV-2 Test-to-Stay in DaycareFelix Dewald, Gertrud Steger, Irina Fish, et al.
Pageof 4